About this Journal Submit a Manuscript Table of Contents
Journal of Neurodegenerative Diseases
Volume 2013 (2013), Article ID 531326, 9 pages
http://dx.doi.org/10.1155/2013/531326
Research Article

Sex Differences in Presynaptic Density and Neurogenesis in Middle-Aged ApoE4 and ApoE Knockout Mice

Department of Anatomy, Donders Centre for Neuroscience, Radboud University Nijmegen Medical Centre, Geert Grooteplein 21, 6525 EZ Nijmegen, The Netherlands

Received 16 November 2012; Accepted 2 January 2013

Academic Editor: Barbara Picconi

Copyright © 2013 A. Rijpma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Kivipelto, T. Ngandu, L. Fratiglioni et al., “Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease,” Archives of Neurology, vol. 62, no. 10, pp. 1556–1560, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. Luchsinger, C. Reitz, L. S. Honig, M. X. Tang, S. Shea, and R. Mayeux, “Aggregation of vascular risk factors and risk of incident Alzheimer disease,” Neurology, vol. 65, no. 4, pp. 545–551, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Pilote, K. Dasgupta, V. Guru, K. H. Humphries, J. McGrath, et al., “A comprehensive view of sex-specific issues related to cardiovascular disease,” Canadian Medical Association Journal, vol. 176, pp. S1–S44, 2007.
  4. A. H. E. M. Maas, Y. T. Van Der Schouw, V. Regitz-Zagrosek, E. Swahn, Y. E. Appelman, et al., “Red alert for womens heart: the urgent need for more research and knowledge on cardiovascular disease in women,” European Heart Journal, vol. 32, pp. 1362–1368, 2011.
  5. A. H. E. M. Maas and Y. E. A. Appelman, “Gender differences in coronary heart disease,” Netherlands Heart Journal, vol. 18, no. 12, pp. 598–603, 2010. View at Scopus
  6. M. Abbey, A. Owen, M. Suzakawa, P. Roach, and P. J. Nestel, “Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL-receptor activity,” Maturitas, vol. 33, no. 3, pp. 259–269, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. A. C. Villablanca, M. Jayachandran, and C. Banka, “Atherosclerosis and sex hormones: current concepts,” Clinical Science, vol. 119, no. 12, pp. 493–513, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. E. H. Corder, A. M. Saunders, W. J. Strittmatter et al., “Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families,” Science, vol. 261, no. 5123, pp. 921–923, 1993. View at Scopus
  9. W. J. Strittmatter, A. M. Saunders, D. Schmechel et al., “Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 5, pp. 1977–1981, 1993. View at Scopus
  10. L. A. Farrer, L. A. Cupples, J. L. Haines et al., “Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis,” Journal of the American Medical Association, vol. 278, no. 16, pp. 1349–1356, 1997. View at Scopus
  11. C. J. Packard, R. G. J. Westendorp, D. J. Stott et al., “Association between apolipoprotein E4 and cognitive decline in elderly adults,” Journal of the American Geriatrics Society, vol. 55, no. 11, pp. 1777–1785, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. D. Flory, S. B. Manuck, R. E. Ferrell, C. M. Ryan, and M. F. Muldoon, “Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults,” American Journal of Medical Genetics, vol. 96, no. 6, pp. 707–711, 2000. View at Scopus
  13. M. W. Bondi, D. P. Salmon, A. U. Monsch et al., “Episodic memory changes are associated with the APOE-ε4 allele in nondemented older adults,” Neurology, vol. 45, no. 12, pp. 2203–2206, 1995. View at Scopus
  14. T. Reed, D. Carmelli, G. E. Swan et al., “Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ε4 allele,” Archives of Neurology, vol. 51, no. 12, pp. 1189–1192, 1994. View at Scopus
  15. J. R. Lynch, D. Morgan, J. Mance, W. D. Matthew, and D. T. Laskowitz, “Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response,” Journal of Neuroimmunology, vol. 114, no. 1-2, pp. 107–113, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Miyata and J. D. Smith, “Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides,” Nature Genetics, vol. 14, no. 1, pp. 55–61, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Huang, “Mechanisms linking apolipoprotein e isoforms with cardiovascular and neurological diseases,” Current Opinion in Lipidology, vol. 21, no. 4, pp. 337–345, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. K. Lahiri, B. Maloney, and R. S. Larry, “Genomics of brain aging: apolipoprotein E,” in Encyclopedia of Neuroscience, pp. 685–693, Academic Press, Oxford, UK, 2009.
  19. J. Davignon, “Apolipoprotein E and atherosclerosis beyond lipid effect,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 2, pp. 267–269, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. R. W. Mahley, “Apolipoprotein E: cholesterol transport protein with expanding role in cell biology,” Science, vol. 240, no. 4852, pp. 622–630, 1988. View at Scopus
  21. J. S. Gong, M. Kobayashi, H. Hayashi et al., “Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice,” Journal of Biological Chemistry, vol. 277, no. 33, pp. 29919–29926, 2002. View at Scopus
  22. R. D. Bell, A. P. Sagare, A. E. Friedman et al., “Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system,” Journal of Cerebral Blood Flow and Metabolism, vol. 27, no. 5, pp. 909–918, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Klann and T. E. Dever, “Biochemical mechanisms for translational regulation in synaptic plasticity,” Nature Reviews Neuroscience, vol. 5, no. 12, pp. 931–942, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. N. A. Johnson, G. H. Jahng, M. W. Weiner et al., “Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience,” Radiology, vol. 234, no. 3, pp. 851–859, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Hirao, T. Ohnishi, Y. Hirata et al., “The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT,” NeuroImage, vol. 28, no. 4, pp. 1014–1021, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Bartrés-Faz, C. Junqué, P. Moral, A. López-Alomar, J. Sánchez-Aldeguer, and I. C. Clemente, “Apolipoprotein E gender effects on cognitive performance in age-associated memory impairment,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 14, no. 1, pp. 80–83, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. E. L. Mortensen and P. Høgh, “A gender difference in the association between APOE genotype and age-related cognitive decline,” Neurology, vol. 57, no. 1, pp. 89–95, 2001. View at Scopus
  28. P. M. Bretsky, J. G. Buckwalter, T. E. Seeman et al., “Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease,” Alzheimer Disease and Associated Disorders, vol. 13, no. 4, pp. 216–221, 1999. View at Scopus
  29. J. Raber, D. Wong, M. Buttini et al., “Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 18, pp. 10914–10919, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Bour, J. Grootendorst, E. Vogel et al., “Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks,” Behavioural Brain Research, vol. 193, no. 2, pp. 174–182, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Yaffe, M. Haan, A. Byers, C. Tangen, and L. Kuller, “Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction,” Neurology, vol. 54, no. 10, pp. 1949–1953, 2000. View at Scopus
  32. J. H. Kang and F. Grodstein, “Postmenopausal hormone therapy, timing of initiation, APOE and cognitive decline,” Neurobiology of Aging, vol. 33, pp. 1129–1137, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. B. P. Nathan, A. G. Barsukova, F. Shen, M. McAsey, and R. G. Struble, “Estrogen facilitates neurite extension via apolipoprotein E in cultured adult mouse cortical neurons,” Endocrinology, vol. 145, no. 7, pp. 3065–3073, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Levin-Allerhand, B. S. McEwen, C. E. Lominska, D. B. Lubahn, K. S. Korach, and J. D. Smith, “Brain region-specific up-regulation of mouse apolipoprotein E by pharmacological estrogen treatments,” Journal of Neurochemistry, vol. 79, no. 4, pp. 796–803, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. K. B. J. Franklin and G. Paxinos, The Mouse Brain in Stereotaxic Coordinates, Academic Press, San Diego, Calif, USA, 1997.
  36. O. Levi, A. L. Jongen-Relo, J. Feldon, and D. M. Michaelson, “Brain area- and isoform-specific inhibition of synaptic plasticity by apoE4,” Journal of the Neurological Sciences, vol. 229-230, pp. 241–248, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. I. Veinbergs, M. Mallory, M. Mante, E. Rockenstein, J. R. Gilbert, and E. Masliah, “Differential neurotrophic effects of apolipoprotein E in aged transgenic mice,” Neuroscience Letters, vol. 265, no. 3, pp. 218–222, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. S. W. Scheff, D. A. Price, F. A. Schmitt, S. T. Dekosky, and E. J. Mufson, “Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment,” Neurology, vol. 68, no. 18, pp. 1501–1508, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. S. W. Scheff, D. A. Price, F. A. Schmitt, and E. J. Mufson, “Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment,” Neurobiology of Aging, vol. 27, no. 10, pp. 1372–1384, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. P. H. Reddy, G. Mani, B. S. Park et al., “Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction,” Journal of Alzheimer's Disease, vol. 7, no. 2, pp. 103–117, 2005. View at Scopus
  41. M. P. Witter, “The perforant path: projections from the entorhinal cortex to the dentate gyrus,” Progress in Brain Research, vol. 163, pp. 43–61, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Dimoka, S. H. Courellis, V. Z. Marmarelis, and T. W. Berger, “Modeling the nonlinear dynamic interactions of afferent pathways in the dentate gyrus of the hippocampus,” Annals of Biomedical Engineering, vol. 36, no. 5, pp. 852–864, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Den Heijer, L. J. Launer, N. D. Prins et al., “Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe,” Neurology, vol. 64, no. 2, pp. 263–267, 2005. View at Scopus
  44. E. S. C. Korf, L. R. White, P. Scheltens, and L. J. Launer, “Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia aging study,” Hypertension, vol. 44, no. 1, pp. 29–34, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. A. M. Stranahan and M. P. Mattson, “Selective vulnerability of neurons in layer II of the entorhinal cortex during aging and Alzheimer's disease,” Neural Plasticity, vol. 2010, Article ID 108190, 8 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. M. A. Yassa, L. T. Muftuler, and C. E. L. Stark, “Ultrahigh-resolution microstructural diffusion tensor imaging reveals perforant path degradation in aged humans in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 28, pp. 12687–12691, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. D. J. Froc, B. Eadie, A. M. Li, K. Wodtke, M. Tse, and B. R. Christie, “Reduced synaptic plasticity in the lateral perforant path input to the dentate gyrus of aged C57BL/6 mice,” Journal of Neurophysiology, vol. 90, no. 1, pp. 32–38, 2003. View at Scopus
  48. A. H. Gazzaley, S. J. Siegel, J. H. Kordower, E. J. Mufson, and J. H. Morrison, “Circuit-specific alterations of N-methyl-D-aspartate receptor subunit 1 in the dentate gyrus of aged monkeys,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 7, pp. 3121–3125, 1996. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Li, N. Bien-Ly, Y. Andrews-Zwilling et al., “GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice,” Cell Stem Cell, vol. 5, no. 6, pp. 634–645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Jansen, C. I. F. Janssen, T. Vanmierlo, T. D, et al., “Cholesterol and synaptic compensatory mechanisms in Alzheimer's Disease mice brain during aging,” Journal of Alzheimer's Disease, vol. 31, no. 4, pp. 813–826, 2012.
  51. O. Levi and D. M. Michaelson, “Environmental enrichment stimulates neurogenesis in apolipoprotein E3 and neuronal apoptosis in apolipoprotein E4 transgenic mice,” Journal of Neurochemistry, vol. 100, no. 1, pp. 202–210, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Jin, A. L. Peel, X. O. Mao et al., “Increased hippocampal neurogenesis in Alzheimer's disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 1, pp. 343–347, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. O. Liraz, A. Haas, and D. M. Michaelson ", “ApoE4 induces synaptic deficits in young mice,” in Alzheimer’s and Parkinson’s Diseases: Advances, Concepts and New Challenges, R. M. Nitsch, A. Fisher, M. Windisch, and I. Hanin, Eds., vol. 8, supplement 1, S. Karger/Medical and Scientific Publishers, Barcelona, Spain, 2011.
  54. K. Boekhoorn, M. Joels, and P. J. Lucassen, “Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus,” Neurobiology of Disease, vol. 24, no. 1, pp. 1–14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. M. H. Donovan, U. Yazdani, R. D. Norris, D. Games, D. C. German, and A. J. Eisch, “Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease,” Journal of Comparative Neurology, vol. 495, no. 1, pp. 70–83, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. P. H. Wen, P. R. Hof, X. Chen et al., “The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice,” Experimental Neurology, vol. 188, no. 2, pp. 224–237, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Jin, V. Galvan, L. Xie et al., “Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APP Sw,Ind) mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 36, pp. 13363–13367, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. M. E. Mendelsohn and R. H. Karas, “The protective effects of estrogen on the cardiovascular system,” The New England Journal of Medicine, vol. 340, no. 23, pp. 1801–1811, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. V. Vaccarino, L. Badimon, R. Corti, et al., “Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position Paper from the Working Group on Coronary Pathophysiology and Microcirculation of the European Society of Cardiology,” Cardiovascular Research, vol. 90, pp. 9–17, 2011.
  60. K. Kublickiene and L. Luksha, “Gender and the endothelium,” Pharmacological Reports, vol. 60, no. 1, pp. 49–60, 2008. View at Scopus
  61. J. C. Lambert, N. Coyle, and C. Lendon, “The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease,” Journal of Medical Genetics, vol. 41, no. 2, pp. 104–112, 2004. View at Scopus
  62. M. X. Tang, D. Jacobs, Y. Stern et al., “Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease,” The Lancet, vol. 348, no. 9025, pp. 429–432, 1996. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Kawas, S. Resnick, A. Morrison et al., “A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging,” Neurology, vol. 48, no. 6, pp. 1517–1521, 1997. View at Scopus
  64. M. I. Geerlings, A. Ruitenberg, J. C. M. Witteman et al., “Reproductive period and risk of dementia in postmenopausal women,” Journal of the American Medical Association, vol. 285, no. 11, pp. 1475–1481, 2001. View at Scopus
  65. J. Raber, G. Bongers, A. LeFevour, M. Buttini, and L. Mucke, “Androgens protect against apolipoprotein E4-induced cognitive deficits,” Journal of Neuroscience, vol. 22, no. 12, pp. 5204–5209, 2002. View at Scopus
  66. Y. Guo, C. Zhang, X. Du, U. Nair, and T. J. Yoo, “Morphological and functional alterations of the cochlea in apolipoprotein E gene deficient mice,” Hearing Research, vol. 208, no. 1-2, pp. 54–67, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. L. V. D'Uscio, T. A. Baker, C. B. Mantilla et al., “Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 6, pp. 1017–1022, 2001. View at Scopus
  68. Y. X. Wang, “Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice,” Neurobiology of Aging, vol. 26, no. 3, pp. 309–316, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. C. G. Specht and R. Schoepfer, “Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice,” BMC Neuroscience, vol. 2, article 11, 2001. View at Publisher · View at Google Scholar · View at Scopus
  70. I. Gureviciene, K. Gurevicius, and H. Tanila, “Role of α-synuclein in synaptic glutamate release,” Neurobiology of Disease, vol. 28, no. 1, pp. 83–89, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. L. Yavich, H. Tanila, S. Vepsäläinen, and P. Jäkälä, “Role of α-synuclein in presynaptic dopamine recruitment,” Journal of Neuroscience, vol. 24, no. 49, pp. 11165–11170, 2004. View at Publisher · View at Google Scholar · View at Scopus
  72. L. Yavich, P. Jäkälä, and H. Tanila, “Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in α-synuclein knockout and A30P transgenic mice,” Journal of Neurochemistry, vol. 99, no. 3, pp. 724–732, 2006. View at Publisher · View at Google Scholar · View at Scopus